SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $509 | -24.0% | 807,535 | 0.0% | 0.16% | -18.3% |
Q2 2023 | $670 | +88.7% | 807,535 | 0.0% | 0.19% | +85.4% |
Q1 2023 | $355 | -25.4% | 807,535 | 0.0% | 0.10% | -28.5% |
Q4 2022 | $476 | -99.9% | 807,535 | 0.0% | 0.14% | -22.2% |
Q3 2022 | $566,000 | -40.2% | 807,535 | +23.8% | 0.18% | -34.4% |
Q2 2022 | $946,000 | -85.5% | 652,440 | -21.6% | 0.28% | -83.2% |
Q4 2021 | $6,502,000 | – | 832,555 | – | 1.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First PREMIER Bank | 652,440 | $946,000 | 0.28% |
METEORA CAPITAL, LLC | 292,538 | $424,000 | 0.08% |
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 78,115 | $113,000 | 0.02% |
SILVER OAK SECURITIES, Inc | 51,941 | $64,000 | 0.01% |
Shaolin Capital Management LLC | 275,000 | $399,000 | 0.01% |
Elgethun Capital Management | 13,296 | $18,000 | 0.01% |
LGL PARTNERS, LLC | 23,000 | $33,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,000 | $122,000 | 0.00% |
Spectrum Management Group, LLC | 5,030 | $7,000 | 0.00% |
Veritable, L.P. | 43,551 | $63,000 | 0.00% |